
### [MONDO:0017969](http://purl.obolibrary.org/obo/MONDO_0017969)
**Label:** 46,XY disorder of sex development of endocrine origin

**Subclasses:** [MONDO:0013310](http://purl.obolibrary.org/obo/MONDO_0013310) (congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency), [MONDO:0017973](http://purl.obolibrary.org/obo/MONDO_0017973) (non-classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0019931](http://purl.obolibrary.org/obo/MONDO_0019931) (leydig cell hypoplasia due to partial LH resistance), [MONDO:0017974](http://purl.obolibrary.org/obo/MONDO_0017974) (46,XY disorder of sex development induced by maternal-exposure to endocrine disruptors), [MONDO:0017971](http://purl.obolibrary.org/obo/MONDO_0017971) (46,XY disorder of sex development due to a cholesterol synthesis defect), [MONDO:0017972](http://purl.obolibrary.org/obo/MONDO_0017972) (classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0019930](http://purl.obolibrary.org/obo/MONDO_0019930) (leydig cell hypoplasia due to complete LH resistance), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0017970](http://purl.obolibrary.org/obo/MONDO_0017970) (46,XY disorder of sex development due to impaired androgen production), [MONDO:0019595](http://purl.obolibrary.org/obo/MONDO_0019595) (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect), [MONDO:0019155](http://purl.obolibrary.org/obo/MONDO_0019155) (leydig cell hypoplasia), [MONDO:0019596](http://purl.obolibrary.org/obo/MONDO_0019596) (46,XY disorder of sex development due to testicular steroidogenesis defect), [MONDO:0019594](http://purl.obolibrary.org/obo/MONDO_0019594) (46,XY disorder of sex development due to a testosterone synthesis defect), [MONDO:0019154](http://purl.obolibrary.org/obo/MONDO_0019154) (androgen insensitivity syndrome), [MONDO:0009857](http://purl.obolibrary.org/obo/MONDO_0009857) (persistent Mullerian duct syndrome), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0008727](http://purl.obolibrary.org/obo/MONDO_0008727) (congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency), [MONDO:0009916](http://purl.obolibrary.org/obo/MONDO_0009916) (46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency), [MONDO:0020041](http://purl.obolibrary.org/obo/MONDO_0020041) (46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue), [MONDO:0010720](http://purl.obolibrary.org/obo/MONDO_0010720) (partial androgen insensitivity syndrome), [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0013400](http://purl.obolibrary.org/obo/MONDO_0013400) (congenital adrenal insufficiency), [MONDO:0009384](http://purl.obolibrary.org/obo/MONDO_0009384) (leydig cell hypoplasia, type 1), [MONDO:0009223](http://purl.obolibrary.org/obo/MONDO_0009223) (hypogonadotropic hypogonadism 23 with or without anosmia), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0009923](http://purl.obolibrary.org/obo/MONDO_0009923) (46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency), [MONDO:0021023](http://purl.obolibrary.org/obo/MONDO_0021023) (complete androgen insensitivity syndrome), [MONDO:0010035](http://purl.obolibrary.org/obo/MONDO_0010035) (Smith-Lemli-Opitz syndrome), [MONDO:0018618](http://purl.obolibrary.org/obo/MONDO_0018618) (46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect), 

**Mapped go classes:** [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0061458](http://purl.obolibrary.org/obo/GO_0061458) (reproductive system development), [GO:0071373](http://purl.obolibrary.org/obo/GO_0071373) (cellular response to luteinizing hormone stimulus), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0030823](http://purl.obolibrary.org/obo/GO_0030823) (regulation of cGMP metabolic process), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0018393](http://purl.obolibrary.org/obo/GO_0018393) (internal peptidyl-lysine acetylation), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0047035](http://purl.obolibrary.org/obo/GO_0047035) (testosterone dehydrogenase (NAD+) activity), [GO:0050790](http://purl.obolibrary.org/obo/GO_0050790) (regulation of catalytic activity), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:2000355](http://purl.obolibrary.org/obo/GO_2000355) (negative regulation of ovarian follicle development), [GO:0031233](http://purl.obolibrary.org/obo/GO_0031233) (intrinsic component of external side of plasma membrane), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:0071379](http://purl.obolibrary.org/obo/GO_0071379) (cellular response to prostaglandin stimulus), [GO:0031116](http://purl.obolibrary.org/obo/GO_0031116) (positive regulation of microtubule polymerization), [GO:0016655](http://purl.obolibrary.org/obo/GO_0016655) (oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor), [GO:0048808](http://purl.obolibrary.org/obo/GO_0048808) (male genitalia morphogenesis), [GO:0090346](http://purl.obolibrary.org/obo/GO_0090346) (cellular organofluorine metabolic process), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0005640](http://purl.obolibrary.org/obo/GO_0005640) (nuclear outer membrane), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0060599](http://purl.obolibrary.org/obo/GO_0060599) (lateral sprouting involved in mammary gland duct morphogenesis), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0042700](http://purl.obolibrary.org/obo/GO_0042700) (luteinizing hormone signaling pathway), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004303](http://purl.obolibrary.org/obo/GO_0004303) (estradiol 17-beta-dehydrogenase activity), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity), [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0016628](http://purl.obolibrary.org/obo/GO_0016628) (oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0045542](http://purl.obolibrary.org/obo/GO_0045542) (positive regulation of cholesterol biosynthetic process), [GO:0047726](http://purl.obolibrary.org/obo/GO_0047726) (iron-cytochrome-c reductase activity), [GO:0004882](http://purl.obolibrary.org/obo/GO_0004882) (androgen receptor activity), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0006700](http://purl.obolibrary.org/obo/GO_0006700) (C21-steroid hormone biosynthetic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0071394](http://purl.obolibrary.org/obo/GO_0071394) (cellular response to testosterone stimulus), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0071395](http://purl.obolibrary.org/obo/GO_0071395) (cellular response to jasmonic acid stimulus), [GO:0048385](http://purl.obolibrary.org/obo/GO_0048385) (regulation of retinoic acid receptor signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity), [GO:0019102](http://purl.obolibrary.org/obo/GO_0019102) (male somatic sex determination), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0070988](http://purl.obolibrary.org/obo/GO_0070988) (demethylation), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0070859](http://purl.obolibrary.org/obo/GO_0070859) (positive regulation of bile acid biosynthetic process), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0046886](http://purl.obolibrary.org/obo/GO_0046886) (positive regulation of hormone biosynthetic process), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0008211](http://purl.obolibrary.org/obo/GO_0008211) (glucocorticoid metabolic process), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0006703](http://purl.obolibrary.org/obo/GO_0006703) (estrogen biosynthetic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0071384](http://purl.obolibrary.org/obo/GO_0071384) (cellular response to corticosteroid stimulus), [GO:0006704](http://purl.obolibrary.org/obo/GO_0006704) (glucocorticoid biosynthetic process), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0006702](http://purl.obolibrary.org/obo/GO_0006702) (androgen biosynthetic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004769](http://purl.obolibrary.org/obo/GO_0004769) (steroid delta-isomerase activity), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0006706](http://purl.obolibrary.org/obo/GO_0006706) (steroid catabolic process), [GO:0070852](http://purl.obolibrary.org/obo/GO_0070852) (cell body fiber), [GO:2001237](http://purl.obolibrary.org/obo/GO_2001237) (negative regulation of extrinsic apoptotic signaling pathway), [GO:0070974](http://purl.obolibrary.org/obo/GO_0070974) (POU domain binding), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0006709](http://purl.obolibrary.org/obo/GO_0006709) (progesterone catabolic process), [GO:0010524](http://purl.obolibrary.org/obo/GO_0010524) (positive regulation of calcium ion transport into cytosol), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity), [GO:0045726](http://purl.obolibrary.org/obo/GO_0045726) (positive regulation of integrin biosynthetic process), [GO:0060685](http://purl.obolibrary.org/obo/GO_0060685) (regulation of prostatic bud formation), [GO:0008386](http://purl.obolibrary.org/obo/GO_0008386) (cholesterol monooxygenase (side-chain-cleaving) activity), [GO:0045720](http://purl.obolibrary.org/obo/GO_0045720) (negative regulation of integrin biosynthetic process), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0042574](http://purl.obolibrary.org/obo/GO_0042574) (retinal metabolic process), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0042699](http://purl.obolibrary.org/obo/GO_0042699) (follicle-stimulating hormone signaling pathway), [GO:0008941](http://purl.obolibrary.org/obo/GO_0008941) (nitric oxide dioxygenase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0047598](http://purl.obolibrary.org/obo/GO_0047598) (7-dehydrocholesterol reductase activity), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:2000835](http://purl.obolibrary.org/obo/GO_2000835) (negative regulation of androgen secretion), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0033218](http://purl.obolibrary.org/obo/GO_0033218) (amide binding), [GO:0038106](http://purl.obolibrary.org/obo/GO_0038106) (choriogonadotropin hormone binding), [GO:0035634](http://purl.obolibrary.org/obo/GO_0035634) (response to stilbenoid), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030061](http://purl.obolibrary.org/obo/GO_0030061) (mitochondrial crista), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0003382](http://purl.obolibrary.org/obo/GO_0003382) (epithelial cell morphogenesis), [GO:0007620](http://purl.obolibrary.org/obo/GO_0007620) (copulation), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:0001880](http://purl.obolibrary.org/obo/GO_0001880) (Mullerian duct regression), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0007617](http://purl.obolibrary.org/obo/GO_0007617) (mating behavior), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0048570](http://purl.obolibrary.org/obo/GO_0048570) (notochord morphogenesis), [GO:0019395](http://purl.obolibrary.org/obo/GO_0019395) (fatty acid oxidation), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0009918](http://purl.obolibrary.org/obo/GO_0009918) (sterol delta7 reductase activity), [GO:0001758](http://purl.obolibrary.org/obo/GO_0001758) (retinal dehydrogenase activity), [GO:0009917](http://purl.obolibrary.org/obo/GO_0009917) (sterol 5-alpha reductase activity), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0034651](http://purl.obolibrary.org/obo/GO_0034651) (cortisol biosynthetic process), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0006622](http://purl.obolibrary.org/obo/GO_0006622) (protein targeting to lysosome), [GO:0043568](http://purl.obolibrary.org/obo/GO_0043568) (positive regulation of insulin-like growth factor receptor signaling pathway), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0050890](http://purl.obolibrary.org/obo/GO_0050890) (cognition), [GO:0030728](http://purl.obolibrary.org/obo/GO_0030728) (ovulation), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:1903076](http://purl.obolibrary.org/obo/GO_1903076) (regulation of protein localization to plasma membrane), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0060571](http://purl.obolibrary.org/obo/GO_0060571) (morphogenesis of an epithelial fold), [GO:0030283](http://purl.obolibrary.org/obo/GO_0030283) (testosterone dehydrogenase [NAD(P)] activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0047023](http://purl.obolibrary.org/obo/GO_0047023) (androsterone dehydrogenase activity), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0060520](http://purl.obolibrary.org/obo/GO_0060520) (activation of prostate induction by androgen receptor signaling pathway), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0060406](http://purl.obolibrary.org/obo/GO_0060406) (positive regulation of penile erection), [GO:0060769](http://purl.obolibrary.org/obo/GO_0060769) (positive regulation of epithelial cell proliferation involved in prostate gland development), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0048638](http://purl.obolibrary.org/obo/GO_0048638) (regulation of developmental growth), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0001545](http://purl.obolibrary.org/obo/GO_0001545) (primary ovarian follicle growth), [GO:0001546](http://purl.obolibrary.org/obo/GO_0001546) (preantral ovarian follicle growth), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0016132](http://purl.obolibrary.org/obo/GO_0016132) (brassinosteroid biosynthetic process), [GO:0030540](http://purl.obolibrary.org/obo/GO_0030540) (female genitalia development), [GO:0014734](http://purl.obolibrary.org/obo/GO_0014734) (skeletal muscle hypertrophy), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:1990262](http://purl.obolibrary.org/obo/GO_1990262) (anti-Mullerian hormone signaling pathway), [GO:0090181](http://purl.obolibrary.org/obo/GO_0090181) (regulation of cholesterol metabolic process), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development), [GO:0047442](http://purl.obolibrary.org/obo/GO_0047442) (17-alpha-hydroxyprogesterone aldolase activity), [GO:0034699](http://purl.obolibrary.org/obo/GO_0034699) (response to luteinizing hormone), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0016488](http://purl.obolibrary.org/obo/GO_0016488) (farnesol catabolic process), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:0090504](http://purl.obolibrary.org/obo/GO_0090504) (epiboly), [GO:0016229](http://purl.obolibrary.org/obo/GO_0016229) (steroid dehydrogenase activity), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008049](http://purl.obolibrary.org/obo/GO_0008049) (male courtship behavior), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0090030](http://purl.obolibrary.org/obo/GO_0090030) (regulation of steroid hormone biosynthetic process), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:1990272](http://purl.obolibrary.org/obo/GO_1990272) (anti-Mullerian hormone receptor activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045945](http://purl.obolibrary.org/obo/GO_0045945) (positive regulation of transcription by RNA polymerase III), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity), [GO:1902613](http://purl.obolibrary.org/obo/GO_1902613) (negative regulation of anti-Mullerian hormone signaling pathway), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0050850](http://purl.obolibrary.org/obo/GO_0050850) (positive regulation of calcium-mediated signaling), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0072520](http://purl.obolibrary.org/obo/GO_0072520) (seminiferous tubule development), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0071799](http://purl.obolibrary.org/obo/GO_0071799) (cellular response to prostaglandin D stimulus), [GO:0030521](http://purl.obolibrary.org/obo/GO_0030521) (androgen receptor signaling pathway), [GO:0007190](http://purl.obolibrary.org/obo/GO_0007190) (activation of adenylate cyclase activity), [GO:0030522](http://purl.obolibrary.org/obo/GO_0030522) (intracellular receptor signaling pathway), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0042448](http://purl.obolibrary.org/obo/GO_0042448) (progesterone metabolic process), [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity), [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity), [GO:0042562](http://purl.obolibrary.org/obo/GO_0042562) (hormone binding), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0051281](http://purl.obolibrary.org/obo/GO_0051281) (positive regulation of release of sequestered calcium ion into cytosol), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0004128](http://purl.obolibrary.org/obo/GO_0004128) (cytochrome-b5 reductase activity, acting on NAD(P)H), [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0003958](http://purl.obolibrary.org/obo/GO_0003958) (NADPH-hemoprotein reductase activity), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0032770](http://purl.obolibrary.org/obo/GO_0032770) (positive regulation of monooxygenase activity), [GO:1900053](http://purl.obolibrary.org/obo/GO_1900053) (negative regulation of retinoic acid biosynthetic process), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0044597](http://purl.obolibrary.org/obo/GO_0044597) (daunorubicin metabolic process), [GO:0022602](http://purl.obolibrary.org/obo/GO_0022602) (ovulation cycle process), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0044598](http://purl.obolibrary.org/obo/GO_0044598) (doxorubicin metabolic process), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:1903449](http://purl.obolibrary.org/obo/GO_1903449) (androst-4-ene-3,17-dione biosynthetic process), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:0047751](http://purl.obolibrary.org/obo/GO_0047751) (cholestenone 5-alpha-reductase activity), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0048168](http://purl.obolibrary.org/obo/GO_0048168) (regulation of neuronal synaptic plasticity), [GO:0046661](http://purl.obolibrary.org/obo/GO_0046661) (male sex differentiation), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0035472](http://purl.obolibrary.org/obo/GO_0035472) (choriogonadotropin hormone receptor activity), [GO:0043950](http://purl.obolibrary.org/obo/GO_0043950) (positive regulation of cAMP-mediated signaling), [GO:0046544](http://purl.obolibrary.org/obo/GO_0046544) (development of secondary male sexual characteristics), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0003420](http://purl.obolibrary.org/obo/GO_0003420) (regulation of growth plate cartilage chondrocyte proliferation), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity), [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity), [GO:0050482](http://purl.obolibrary.org/obo/GO_0050482) (arachidonic acid secretion), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0004508](http://purl.obolibrary.org/obo/GO_0004508) (steroid 17-alpha-monooxygenase activity), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0061370](http://purl.obolibrary.org/obo/GO_0061370) (testosterone biosynthetic process), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0003073](http://purl.obolibrary.org/obo/GO_0003073) (regulation of systemic arterial blood pressure), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0044255](http://purl.obolibrary.org/obo/GO_0044255) (cellular lipid metabolic process), [GO:0005497](http://purl.obolibrary.org/obo/GO_0005497) (androgen binding), [GO:0060748](http://purl.obolibrary.org/obo/GO_0060748) (tertiary branching involved in mammary gland duct morphogenesis), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0043602](http://purl.obolibrary.org/obo/GO_0043602) (nitrate catabolic process), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0007548](http://purl.obolibrary.org/obo/GO_0007548) (sex differentiation), [GO:0003865](http://purl.obolibrary.org/obo/GO_0003865) (3-oxo-5-alpha-steroid 4-dehydrogenase activity), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0060192](http://purl.obolibrary.org/obo/GO_0060192) (negative regulation of lipase activity), [GO:0050810](http://purl.obolibrary.org/obo/GO_0050810) (regulation of steroid biosynthetic process), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0035457](http://purl.obolibrary.org/obo/GO_0035457) (cellular response to interferon-alpha), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0005026](http://purl.obolibrary.org/obo/GO_0005026) (transforming growth factor beta receptor activity, type II), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0004964](http://purl.obolibrary.org/obo/GO_0004964) (luteinizing hormone receptor activity), [GO:0004963](http://purl.obolibrary.org/obo/GO_0004963) (follicle-stimulating hormone receptor activity), [GO:0008528](http://purl.obolibrary.org/obo/GO_0008528) (G-protein coupled peptide receptor activity), [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development), [GO:0019098](http://purl.obolibrary.org/obo/GO_0019098) (reproductive behavior), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0046210](http://purl.obolibrary.org/obo/GO_0046210) (nitric oxide catabolic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0033148](http://purl.obolibrary.org/obo/GO_0033148) (positive regulation of intracellular estrogen receptor signaling pathway), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), [GO:2000224](http://purl.obolibrary.org/obo/GO_2000224) (regulation of testosterone biosynthetic process), 

**Class expressions from DL-Learner:**

- Thing 57.43%
- [GO:1990272](http://purl.obolibrary.org/obo/GO_1990272) (anti-Mullerian hormone receptor activity) 50.37%
- [GO:0035472](http://purl.obolibrary.org/obo/GO_0035472) (choriogonadotropin hormone receptor activity) 50.37%
- [GO:0004964](http://purl.obolibrary.org/obo/GO_0004964) (luteinizing hormone receptor activity) 50.37%
- [GO:0004963](http://purl.obolibrary.org/obo/GO_0004963) (follicle-stimulating hormone receptor activity) 50.37%
- [GO:0004882](http://purl.obolibrary.org/obo/GO_0004882) (androgen receptor activity) 50.37%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and [GO:0038023](http://purl.obolibrary.org/obo/GO_0038023) (signaling receptor activity) 42.31%
- [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity) and [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 42.31%
- [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 42.31%


